Literature DB >> 24833591

Stable enhanced green fluorescent protein expression after differentiation and transplantation of reporter human induced pluripotent stem cells generated by AAVS1 transcription activator-like effector nucleases.

Yongquan Luo1, Chengyu Liu1, Trevor Cerbini1, Hong San1, Yongshun Lin1, Guokai Chen1, Mahendra S Rao1, Jizhong Zou2.   

Abstract

Human induced pluripotent stem (hiPS) cell lines with tissue-specific or ubiquitous reporter genes are extremely useful for optimizing in vitro differentiation conditions as well as for monitoring transplanted cells in vivo. The adeno-associated virus integration site 1 (AAVS1) locus has been used as a "safe harbor" locus for inserting transgenes because of its open chromatin structure, which permits transgene expression without insertional mutagenesis. However, it is not clear whether targeted transgene expression at the AAVS1 locus is always protected from silencing when driven by various promoters, especially after differentiation and transplantation from hiPS cells. In this paper, we describe a pair of transcription activator-like effector nucleases (TALENs) that enable more efficient genome editing than the commercially available zinc finger nuclease at the AAVS1 site. Using these TALENs for targeted gene addition, we find that the cytomegalovirus-immediate early enhancer/chicken β-actin/rabbit β-globin (CAG) promoter is better than cytomegalovirus 7 and elongation factor 1α short promoters in driving strong expression of the transgene. The two independent AAVS1, CAG, and enhanced green fluorescent protein (EGFP) hiPS cell reporter lines that we have developed do not show silencing of EGFP either in undifferentiated hiPS cells or in randomly and lineage-specifically differentiated cells or in teratomas. Transplanting cardiomyocytes from an engineered AAVS1-CAG-EGFP hiPS cell line in a myocardial infarcted mouse model showed persistent expression of the transgene for at least 7 weeks in vivo. Our results show that high-efficiency targeting can be obtained with open-source TALENs and that careful optimization of the reporter and transgene constructs results in stable and persistent expression in vitro and in vivo. ©AlphaMed Press.

Entities:  

Keywords:  AAVS1; Differentiation; Genome editing; Human induced pluripotent stem cells; Transcription activator-like effector nuclease (TALEN); Transplantation

Mesh:

Substances:

Year:  2014        PMID: 24833591      PMCID: PMC4073825          DOI: 10.5966/sctm.2013-0212

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  29 in total

Review 1.  Cell therapy and the safety of embryonic stem cell-derived grafts.

Authors:  Hannes Hentze; Ralph Graichen; Alan Colman
Journal:  Trends Biotechnol       Date:  2006-11-03       Impact factor: 19.536

2.  Characteristics of the adeno-associated virus preintegration site in human chromosome 19: open chromatin conformation and transcription-competent environment.

Authors:  S Lamartina; E Sporeno; E Fattori; C Toniatti
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation.

Authors:  T Deacon; J Dinsmore; L C Costantini; J Ratliff; O Isacson
Journal:  Exp Neurol       Date:  1998-01       Impact factor: 5.330

4.  Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells.

Authors:  M Mayer-Proschel; A J Kalyani; T Mujtaba; M S Rao
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

5.  The human cytomegalovirus immediate early enhancer-promoter is responsive to activation by the adenovirus-5 13S E1A gene.

Authors:  D M Olive; W al-Mulla; M Simsek; S Zarban; W al-Nakib
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies.

Authors:  Oleg Tarnavski; Julie R McMullen; Martina Schinke; Qing Nie; Sekwon Kong; Seigo Izumo
Journal:  Physiol Genomics       Date:  2004-02-13       Impact factor: 3.107

7.  Identification and targeting of the ROSA26 locus in human embryonic stem cells.

Authors:  Stefan Irion; Hervé Luche; Paul Gadue; Hans Joerg Fehling; Marion Kennedy; Gordon Keller
Journal:  Nat Biotechnol       Date:  2007-11-25       Impact factor: 54.908

8.  Single-copy transgenic mice with chosen-site integration.

Authors:  S K Bronson; E G Plaehn; K D Kluckman; J R Hagaman; N Maeda; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

Review 9.  Assessing iPSC reprogramming methods for their suitability in translational medicine.

Authors:  Mahendra S Rao; Nasir Malik
Journal:  J Cell Biochem       Date:  2012-10       Impact factor: 4.429

10.  Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner.

Authors:  Xiaofeng Xia; Yingsha Zhang; Caroline R Zieth; Su-Chun Zhang
Journal:  Stem Cells Dev       Date:  2007-02       Impact factor: 3.272

View more
  33 in total

1.  CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons.

Authors:  Ruilin Tian; Mariam A Gachechiladze; Connor H Ludwig; Matthew T Laurie; Jason Y Hong; Diane Nathaniel; Anika V Prabhu; Michael S Fernandopulle; Rajan Patel; Mehrnoosh Abshari; Michael E Ward; Martin Kampmann
Journal:  Neuron       Date:  2019-08-15       Impact factor: 17.173

2.  Compounds with species and cell type specific toxicity identified in a 2000 compound drug screen of neural stem cells and rat mixed cortical neurons.

Authors:  Nasir Malik; Anastasia G Efthymiou; Karly Mather; Nathaniel Chester; Xiantao Wang; Avindra Nath; Mahendra S Rao; Joseph P Steiner
Journal:  Neurotoxicology       Date:  2014-10-22       Impact factor: 4.294

3.  Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers.

Authors:  So Gun Hong; Ravi Chandra Yada; Kyujoo Choi; Arnaud Carpentier; T Jake Liang; Randall K Merling; Colin L Sweeney; Harry L Malech; Moonjung Jung; Marcus A F Corat; Aisha A AlJanahi; Yongshun Lin; Huimin Liu; Ilker Tunc; Xujing Wang; Maryknoll Palisoc; Stefania Pittaluga; Manfred Boehm; Thomas Winkler; Jizhong Zou; Cynthia E Dunbar
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

Review 4.  Genome editing in cardiovascular diseases.

Authors:  Alanna Strong; Kiran Musunuru
Journal:  Nat Rev Cardiol       Date:  2016-09-09       Impact factor: 32.419

5.  CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.

Authors:  Joseph C Giacalone; Tasneem P Sharma; Erin R Burnight; John F Fingert; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Curr Protoc Stem Cell Biol       Date:  2018-02-28

6.  Transfection, selection, and colony-picking of human induced pluripotent stem cells TALEN-targeted with a GFP gene into the AAVS1 safe harbor.

Authors:  Trevor Cerbini; Yongquan Luo; Mahendra S Rao; Jizhong Zou
Journal:  J Vis Exp       Date:  2015-02-01       Impact factor: 1.355

7.  Quantification of transgene expression in GSH AAVS1 with a novel CRISPR/Cas9-based approach reveals high transcriptional variation.

Authors:  Anne Inderbitzin; Tom Loosli; Roger D Kouyos; Karin J Metzner
Journal:  Mol Ther Methods Clin Dev       Date:  2022-06-09       Impact factor: 5.849

Review 8.  Enhancing Matured Stem-Cardiac Cell Generation and Transplantation: A Novel Strategy for Heart Failure Therapy.

Authors:  Ampadu O Jackson; Ganiyu A Rahman; Kai Yin; Shiyin Long
Journal:  J Cardiovasc Transl Res       Date:  2020-11-30       Impact factor: 4.132

9.  Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.

Authors:  Vasanth Thamodaran; Sonam Rani; Shaji R Velayudhan
Journal:  Methods Mol Biol       Date:  2022

10.  A platform for rapid generation of single and multiplexed reporters in human iPSC lines.

Authors:  Ying Pei; Guadalupe Sierra; Renuka Sivapatham; Andrzej Swistowski; Mahendra S Rao; Xianmin Zeng
Journal:  Sci Rep       Date:  2015-03-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.